Searching map area
Non-small-cell lung cancer
? TBD
Any type of epithelial lung cancer other than small-cell lung carcinoma
Nobody has rated this yet. Be the first!
Influences rating
Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial
scientific article
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
scientific article (publication date: 22 October 2015)
Treatment outcomes in elderly with advanced-stage non-small cell lung cancer
scientific article published on 09 August 2013
3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer
article by Wouter van Elmpt et al published February 2010 in Radiotherapy and Oncology
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
scientific article published on 06 September 2019
Abstract 1317: Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
scientific article published on 01 November 2019
Molecular pathogenesis of early-stage non-small cell lung cancer and a proposal for tissue banking to facilitate identification of new biomarkers
scientific article published on 01 July 2007
Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells
scientific article
Synergy between vinorelbine and afatinib in the inhibition of non-small cell lung cancer progression by EGFR and p53 signaling pathways
scientific article published on 24 December 2020
Lists 0

Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma. When possible, they are primarily treated by...

Instance of
Subclass of
References